Advanced Medical Isotope (OTCMKTS:RDGL) Releases Quarterly Earnings Results

Advanced Medical Isotope (OTCMKTS:RDGL) posted its quarterly earnings data on Monday. The company reported ($0.01) earnings per share for the quarter, Zacks reports. The company had revenue of $0.02 million for the quarter.

Advanced Medical Isotope Stock Performance

Shares of Advanced Medical Isotope stock traded up $0.00 on Wednesday, hitting $0.09. 368,268 shares of the company traded hands, compared to its average volume of 516,585. Advanced Medical Isotope has a 12-month low of $0.04 and a 12-month high of $0.17. The firm’s 50-day simple moving average is $0.08 and its 200 day simple moving average is $0.08.

Advanced Medical Isotope Company Profile

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc in December 2017. Vivos Inc was incorporated in 1994 and is headquartered in Richland, Washington.